Association of Gestational Cardiovascular Health With Pregnancy Outcomes
Sponsored by Women's Hospital School Of Medicine Zhejiang University
About this trial
Last updated 5 months ago
Study ID
IRB-20230053-R
Status
Recruiting
Type
Observational
Placebo
No
Accepting
20 to 49 Years
Female
Trial Timing
Started 3 years ago
What is this trial about?
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.
What are the participation requirements?
Inclusion Criteria
* Maternal age: 20-49 years;
* Natural conception;
* Single pregnancy;
* Plan to have routine prenatal examinations and give birth in the research center;
Exclusion Criteria
* Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy;
* Assisted reproduction;
* Multiple pregnancy;
* Fetus has a known deformity or genetic defects;
* Incomplete clinical data.